Woman’s Hospital Achieves Globally Recognized Baby-Friendly Designation
March 19, 2018 09:48 ET
|
Woman's Hospital
Baton Rouge, La., March 19, 2018 (GLOBE NEWSWIRE) -- Woman’s Hospital has achieved Baby-Friendly designation from The Baby-Friendly Hospital Initiative, a global program of the World Health...
TrustedHealth Launches Global Network for Treatment of Life-Threatening Diseases, Presenting at World Health Organization
March 13, 2018 09:16 ET
|
TrustedHealth
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- TrustedHealth, a blockchain-based patient and doctor-centric health ecosystem in specialized medicine, is launching to increase access to...
CleanSpace Technology Adds Central Welding Supply to Distribution Network
November 06, 2017 07:30 ET
|
CleanSpace Technology
CHICAGO, Nov. 06, 2017 (GLOBE NEWSWIRE) -- CleanSpace Technology, a global manufacturer of powered air purifying respiratory protection, today announced that Central Welding Supply, the Pacific...
CleanSpace Demonstrates Third Generation Respirator Innovation at A+A International Trade Fair
October 16, 2017 02:01 ET
|
CleanSpace Technology
DUSSELDORF, Germany, Oct. 16, 2017 (GLOBE NEWSWIRE) -- CleanSpace Technology will be introducing their new light-weight, connected and personalized Generation 3 respirator technology at the A+A...
CleanSpace Opens Welding Respiratory Safety Resource Center
September 25, 2017 07:30 ET
|
CleanSpace Technology
CHICAGO, Sept. 25, 2017 (GLOBE NEWSWIRE) -- CleanSpace Technology, a global manufacturer of powered air purifying respiratory protection, today opened its Online Welding Respiratory Safety Resource...
![Sir Emeka Offor Foundation Logo](/news-release/logo/336383/0/336383.jpg?lastModified=12%2F10%2F2016%2012%3A33%3A07&size=2)
Sir Emeka Offor Foundation Vows to Keep Fighting Polio After Defeat of Disease in Nigeria
July 23, 2015 14:19 ET
|
Sir Emeka Offor Foundation
ABUJA, Nigeria, July 23, 2015 (GLOBE NEWSWIRE) -- The Sir Emeka Offor Foundation, a non-governmental, philanthropic organization focused on healthcare, youth employment, families, education and...
Hemispherx Announces Primate Research Showing Alferon(R) LDO Protection From Pulmonary Damage Associated With Infection by Highly Pathogenic Influenza Virus
September 22, 2014 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Sept. 22, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced today a peer-reviewed publication entitled "Protection from...
Hemispherx Biopharma and the Swiss Department of Defense, Civil Protection and Sports Expand Their Collaborative Research Agreement to Include the Study of Alferon(R) and Ampligen(R) Against the Ebola Virus
September 10, 2014 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Sept. 10, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE:HEB) (the "Company" or "Hemispherx"), announced that it expanded its Collaborative Research Agreement to test...
Hemispherx Achieves High Ranking in Sensitivity Testing Against MERS/SARS Coronaviruses Compared to Other Drugs
July 22, 2014 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, July 22, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced that a new publication abstract in Infectious Disorder Drug Targets (2014 Jul 13. [Epub ahead of print])...
ICare4Autism Announces New World Health Organization (WHO) Partnership
September 18, 2013 07:34 ET
|
ICare4Autism
NEW YORK, NY--(Marketwired - Sep 18, 2013) - On the 15th of September, the WHO convened its first consultation in Geneva to identify priorities for action and effective strategy to build capacity,...